The estimated Net Worth of Rock Ventures Lp Third Rock... is at least $284 Milion dollars as of 23 March 2017. Rock Rock owns over 1,650,000 units of Rhythm Pharmaceuticals stock worth over $254,949,860 and over the last 9 years Rock sold RYTM stock worth over $28,693,500.
Rock has made over 1 trades of the Rhythm Pharmaceuticals stock since 2017, according to the Form 4 filled with the SEC. Most recently Rock sold 1,650,000 units of RYTM stock worth $28,693,500 on 23 March 2017.
The largest trade Rock's ever made was selling 1,650,000 units of Rhythm Pharmaceuticals stock on 23 March 2017 worth over $28,693,500. On average, Rock trades about 206,250 units every 0 days since 2015. As of 23 March 2017 Rock still owns at least 5,170,348 units of Rhythm Pharmaceuticals stock.
You can see the complete history of Rock Rock stock trades at the bottom of the page.
Over the last 13 years, insiders at Rhythm Pharmaceuticals have traded over $83,445,563 worth of Rhythm Pharmaceuticals stock and bought 6,290,000 units worth $106,961,700 . The most active insiders traders include Forest Baskett, Scott D Sandell a Peter J Barris. On average, Rhythm Pharmaceuticals executives and independent directors trade stock every 17 days with the average trade being worth of $3,358,405. The most recent stock trade was executed by Pamela J. Cramer on 9 September 2024, trading 4,099 units of RYTM stock currently worth $77,963.
rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.
Rhythm Pharmaceuticals executives and other stock owners filed with the SEC include: